Company press releases

Displaying 51 - 100 of 104 results
Released Company Title Industry Topic
09 Oct 2023
17:45 CEST 		EUROAPI SA EUROAPI: Full-Year 2023 Outlook Revised Downwards 20103015 Pharmaceuticals Other subject
09 Oct 2023
17:45 CEST 		EUROAPI SA EUROAPI : Objectifs 2023 revus à la baisse 20103015 Pharmaceuticals Other subject
29 Aug 2023
07:00 CEST 		EUROAPI SA EUROAPI to Acquire BianoGMP to Strengthen its CDMO Expertise in the High-Growth oligonucleotide Market 20103015 Pharmaceuticals Other subject
29 Aug 2023
07:00 CEST 		EUROAPI SA EUROAPI va acquérir BianoGMP pour renforcer son expertise CDMO sur le marché en forte croissance des oligonucléotides 20103015 Pharmaceuticals Other subject
02 Aug 2023
17:45 CEST 		EUROAPI SA EUROAPI : Mise à disposition du Rapport financier semestriel 2023 20103015 Pharmaceuticals Corporate life
02 Aug 2023
17:45 CEST 		EUROAPI SA EUROAPI: Availability of 2023 Half-Year Financial Report 20103015 Pharmaceuticals Corporate life
01 Aug 2023
07:00 CEST 		EUROAPI SA EUROAPI: H1 2023 RESULTS 20103015 Pharmaceuticals Other subject
01 Aug 2023
07:00 CEST 		EUROAPI SA EUROAPI : RESULTATS SEMESTRIELS 2023 20103015 Pharmaceuticals Other subject
13 Jun 2023
13:55 CEST 		EUROAPI SA Health Sovereignty: EUROAPI Supports the Supply of Essential Medicines to France and Europe 20103015 Pharmaceuticals Other subject
13 Jun 2023
13:55 CEST 		EUROAPI SA Souveraineté sanitaire : EUROAPI se mobilise en faveur de l’approvisionnement de la France et de l’Europe en médicaments essentiels 20103015 Pharmaceuticals Other subject
06 Jun 2023
17:45 CEST 		EUROAPI SA EUROAPI to Invest €50 Million at Its Budapest Site to Meet the Growing Demand for Prostaglandins 20103015 Pharmaceuticals Other subject
06 Jun 2023
17:45 CEST 		EUROAPI SA EUROAPI va investir 50 millions d’euros sur son site de Budapest pour répondre à la demande croissante de prostaglandines 20103015 Pharmaceuticals Other subject
11 May 2023
18:00 CEST 		EUROAPI SA EUROAPI : Assemblée Générale Mixte du 11 mai 2023 20103015 Pharmaceuticals Other subject
11 May 2023
18:00 CEST 		EUROAPI SA EUROAPI: Combined General Meeting of May 11, 2023 20103015 Pharmaceuticals Other subject
10 May 2023
20:18 CEST 		EUROAPI SA EUROAPI’s Board of Directors Proposes Géraldine Leveau as Director 20103015 Pharmaceuticals Other subject
10 May 2023
20:18 CEST 		EUROAPI SA Le Conseil d’administration d’EUROAPI propose Géraldine Leveau en tant qu’administrateur 20103015 Pharmaceuticals Other subject
09 May 2023
07:00 CEST 		EUROAPI SA EUROAPI and Novéal sign CDMO agreement to advance cosmetic projects 20103015 Pharmaceuticals Other subject
09 May 2023
07:00 CEST 		EUROAPI SA EUROAPI et Novéal signent un accord de CDMO pour des projets dans le domaine de la cosmétique 20103015 Pharmaceuticals Other subject
26 Apr 2023
18:00 CEST 		EUROAPI SA EUROAPI: Availability of the Amendment n°1 of the 2022 Universal Registration Document 20103015 Pharmaceuticals Other subject
26 Apr 2023
18:00 CEST 		EUROAPI SA EUROAPI : Mise à disposition de l’Amendement n°1 du Document d’Enregistrement Universel 2022 20103015 Pharmaceuticals Other subject
14 Apr 2023
23:00 CEST 		EUROAPI SA EUROAPI: Availability of the 2022 Universal Registration Document, Including the Annual Financial Report 20103015 Pharmaceuticals Other subject
14 Apr 2023
23:00 CEST 		EUROAPI SA EUROAPI : Mise à disposition du Document d’Enregistrement Universel 2022, contenant le Rapport Financier Annuel 20103015 Pharmaceuticals Other subject
08 Mar 2023
07:00 CET 		EUROAPI SA EUROAPI: Full-Year 2022 Results 20103015 Pharmaceuticals Other subject
08 Mar 2023
07:00 CET 		EUROAPI SA EUROAPI : RESULTATS ANNUELS 2022 20103015 Pharmaceuticals Other subject
31 Jan 2023
07:00 CET 		EUROAPI SA EUROAPI: Progressive restart of prostaglandin production at Budapest site 20103015 Pharmaceuticals Other subject
31 Jan 2023
07:00 CET 		EUROAPI SA EUROAPI : Redémarrage progressif de la production de prostaglandines sur le site de Budapest 20103015 Pharmaceuticals Other subject
11 Jan 2023
18:00 CET 		EUROAPI SA EUROAPI’s Board of Directors Proposes Mattias Perjos as Independent Director 20103015 Pharmaceuticals Other subject
11 Jan 2023
18:00 CET 		EUROAPI SA Le Conseil d’administration d’EUROAPI propose Mattias Perjos en tant qu’administrateur indépendant 20103015 Pharmaceuticals Other subject
09 Jan 2023
07:00 CET 		EUROAPI SA Vitamine B12 : EUROAPI va investir 40 millions d’euros dans un procédé de production plus efficace et durable en France 20103015 Pharmaceuticals Other subject
09 Jan 2023
07:00 CET 		EUROAPI SA Vitamin B12: EUROAPI to Invest €40 Million for a More Efficient and Sustainable Production Process in France 20103015 Pharmaceuticals Other subject
07 Dec 2022
07:00 CET 		EUROAPI SA  EUROAPI actualise ses prévisions financières 2022 20103015 Pharmaceuticals Other subject
07 Dec 2022
07:00 CET 		EUROAPI SA EUROAPI Updates Its 2022 Financial Guidance 20103015 Pharmaceuticals Other subject
31 Oct 2022
18:00 CET 		EUROAPI SA EUROAPI va porter les capacités de fabrication de peptides et d’oligonucléotides de son site de Francfort à 500 kg par an d’ici à 2025 20103015 Pharmaceuticals Other subject
31 Oct 2022
18:00 CET 		EUROAPI SA EUROAPI to Reach 500 kg Peptide and Oligonucleotide Capacity Per Year in Frankfurt by 2025 20103015 Pharmaceuticals Other subject
01 Sep 2022
07:30 CEST 		EUROAPI SA EUROAPI: Availability of 2022 Half-Year Financial Report 20103015 Pharmaceuticals Other subject
01 Sep 2022
07:30 CEST 		EUROAPI SA EUROAPI : Mise à disposition du Rapport financier semestriel 2022 20103015 Pharmaceuticals Other subject
01 Sep 2022
07:00 CEST 		EUROAPI SA EUROAPI: Solid Business and Financial Performance in H1-2022 - Net Sales and Core EBITDA Margin Guidance for 2022 Confirmed 20103015 Pharmaceuticals Other subject
01 Sep 2022
07:00 CEST 		EUROAPI SA EUROAPI : Solide performance opérationnelle et financière au S1-2022 - Objectifs annuels 2022 de chiffre d’affaires et de marge de Core EBITDA confirmés 20103015 Pharmaceuticals Other subject
22 Jul 2022
07:00 CEST 		EUROAPI SA EUROAPI Announces the Success of Its First Global Employee Share Plan “EUROAPI Action 2022” 20103015 Pharmaceuticals Other subject
22 Jul 2022
07:00 CEST 		EUROAPI SA EUROAPI annonce le succès de son premier plan mondial d’actionnariat salarié « EUROAPI Action 2022 » 20103015 Pharmaceuticals Other subject
21 Jul 2022
07:00 CEST 		EUROAPI SA ESG: EUROAPI Moves Forward With Its Carbon Reduction Ambition and Invests to Build a State-of-the-Art Biomass Boiler in France 20103015 Pharmaceuticals Other subject
21 Jul 2022
07:00 CEST 		EUROAPI SA ESG : EUROAPI poursuit son ambition de réduction de ses émissions de carbone et investit dans la construction d’une chaufferie biomasse de pointe en France 20103015 Pharmaceuticals Other subject
01 Jul 2022
18:00 CEST 		EUROAPI SA Availability of EUROAPI’s 2021 Half-Year Results 20103015 Pharmaceuticals Other subject
01 Jul 2022
18:00 CEST 		EUROAPI SA Mise à disposition des résultats semestriels 2021 d’EUROAPI 20103015 Pharmaceuticals Other subject
09 Jun 2022
20:20 CEST 		EUROAPI SA EUROAPI rejoint les indices SBF 120 et CAC Mid 60 20103015 Pharmaceuticals Other subject
09 Jun 2022
20:20 CEST 		EUROAPI SA EUROAPI joins the SBF 120 and CAC Mid 60 indices 20103015 Pharmaceuticals Other subject
03 Jun 2022
18:30 CEST 		EUROAPI SA EUROAPI lance son premier plan mondial d’actionnariat salarié EUROAPI Action 2022 20103015 Pharmaceuticals Other subject
03 Jun 2022
18:30 CEST 		EUROAPI SA EUROAPI launches its first global employee share plan “EUROAPI Action 2022” 20103015 Pharmaceuticals Other subject
01 Jun 2022
07:00 CEST 		EUROAPI SA EUROAPI met en œuvre un contrat de liquidité avec Kepler Cheuvreux 20103015 Pharmaceuticals Other subject
01 Jun 2022
07:00 CEST 		EUROAPI SA EUROAPI Implements a Liquidity Contract With Kepler Cheuvreux 20103015 Pharmaceuticals Other subject